Join
Live feed
·
INSIDERFilingvia Quantisnow
iTeos Therapeutics Inc. logo

Chief Operating Officer Call Matthew closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ITOS· iTeos Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ITOS (iTeos Therapeutics Inc.) and more on Quantisnow.